An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
14 of Top 20 Global Pharma Companies Use ON24 to Drive Digital Engagement with Healthcare Professionals
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
ON24 (NYSE: ONTF) highlights the increasing adoption of digital engagement in the life sciences sector, helping companies connect with healthcare professionals (HCPs) through virtual events and other digital experiences. Over 135 life sciences companies, including 14 of the 20 largest pharmaceutical companies, utilize ON24's platform to enhance HCP engagement and support product launches. The company offers various tools such as webinars and multimedia content to optimize communications and improve patient outcomes.
Positive
Over 135 life sciences companies use ON24, including 14 of the top 20 pharmaceutical companies.
The platform enables improved digital engagement with healthcare professionals.
ON24 offers actionable insights and tools for sales and marketing teams.
Negative
None.
Webinar, virtual event, and multimedia content experiences help leading life sciences companies connect with HCPs, launch new medicines, and improve patient outcomes
SAN FRANCISCO & LONDON--(BUSINESS WIRE)--
The life sciences industry is quickly transitioning to digital-first engagement with healthcare professionals (HCPs). To meet this pressing need, an increasing number of pharmaceutical, biotech, and medical device companies are using ON24 (NYSE: ONTF) to connect with HCPs and digitally launch new products. More than 135 life sciences companies, including 14 of the top 20 largest global pharmaceutical companies, are leveraging ON24 digital experiences to scale HCP engagement globally, educate doctors on new medicines, and maximize the impact of their commercial launches.
With in-person engagement changing and access to busy HCPs declining, companies are accelerating their digital transformation initiatives to deliver more live virtual events and on-demand content that connect with their audiences. ON24 interactive webinars, custom virtual conferences, and multimedia content experiences enable sales and marketing teams to reach HCPs through their preferred digital channels and get them the expert scientific information they need to drive better patient outcomes.
Life sciences companies are keeping sales reps and medical science liaisons engaged with HCPs on the latest treatments and therapeutics through virtual lectures, seminars, and conferences using ON24 Webcast Elite, ON24 Virtual Conference, and ON24 Breakouts. Branded content hubs with ON24 Engagement Hub provide a single destination for HCPs to digitally access the latest product information and patient-facing materials, as well as engage sales teams.
All ON24 digital experiences provide actionable insights for personalized content and sales follow-up. With over 20 engagement and conversion tools, including Q&As, surveys, polls, and CTAs, companies can leverage ON24 Intelligence and a powerful AI-engine to deliver personalized content to HCPs based on behaviors and interests, provide sales and marketing the next best action to take, and drive HCPs to branded content hubs or company websites.
ON24 Connect can seamlessly integrate first-person engagement data with leading third-party systems, including Veeva CRM Events Management, to inform and trigger actions across marketing and sales. With the ability to create high-valued engagement and capture meaningful audience insights, life sciences companies can strengthen HCP relationships and maximize the successful digital launch of breakthrough treatments for patients.
“Life sciences is reimagining engagement with healthcare professionals in a digital-first world and driving better awareness, education, and adoption of therapies and treatments,” said Shalini Mitha, vice president of product, solutions, and industries marketing at ON24. “We’re helping some of the world’s most innovative pharmaceutical, biotech, and medical device companies accelerate their digital-first commercial execution and connect with busy doctors the way they want.”
The ON24 Platform includes ON24 Webcast Elite, ON24 Virtual Conference, ON24 Breakouts, ON24 Engagement Hub, ON24 Target, ON24 Intelligence, and ON24 Connect. To learn how leading life sciences companies, including AbbVie, Eli Lilly, and Roche, deliver digital experiences that create deep HCP engagement, first-person data, and AI-driven personalization, as well as seamlessly integrate audience insights with sales and marketing systems, visit ON24.com/solutions/life-sciences/.
About ON24
ON24 provides a leading cloud-based hybrid engagement platform that makes it easy to create, scale, and personalize engaging experiences to drive measurable business growth. Today, we are helping over 2,000 companies worldwide, including 3 of the 5 largest global technology companies, 4 of the 5 largest US banks, 3 of the 5 largest global healthcare companies, and 3 of the 5 largest global industrial manufacturing companies, convert millions of prospects to buyers. Through interactive webinars, virtual events, and always-on multimedia experiences, ON24 provides a system of engagement, powered by AI, which enables businesses to scale engagement, conversions, and pipeline to drive revenue growth. The ON24 platform supports millions of professionals a month who are totaling billions of engagement minutes per year. ON24 is headquartered in San Francisco with global offices in North America, EMEA, and APAC. For more information, visit www.ON24.com.
Forward-Looking Statements
This document contains “forward-looking statements” under applicable securities laws. In some cases, such statements can be identified by words such as: “expect,” “convert,” “believe,” “plan,” “future,” “may,” “should,” “will,” and similar references to future periods. Forward-looking statements include express or implied statements regarding our ability to achieve our business strategies, growth, or other future events or conditions. Such statements are based on our current beliefs, expectations, and assumptions about future events or conditions, which are subject to inherent risks and uncertainties, including the risks and uncertainties discussed in the filings we make from time to time with the Securities and Exchange Commission. Actual results may differ materially from those indicated in forward-looking statements, and you should not place undue reliance on them. All statements herein are based only on information currently available to us and speak only as of the date hereof. Except as required by law, we undertake no obligation to update any such statement.
ON24 provides digital engagement solutions that help life sciences companies connect with healthcare professionals through virtual events, webinars, and multimedia content.
How many life sciences companies are using ON24?
More than 135 life sciences companies are leveraging ON24's platform for enhanced HCP engagement.
Which major pharmaceutical companies use ON24?
14 of the top 20 largest global pharmaceutical companies utilize ON24 to optimize their digital engagement strategies.
What tools does ON24 provide for HCP engagement?
ON24 offers tools such as interactive webinars, virtual conferences, and multimedia content experiences to support HCP engagement.
